Omer Trivizki discusses promising results of VOY-101, a gene therapy for geographic atrophy, highlighting safety and next steps in ongoing research.
Omer Trivizki, MD, MBA
Advertisement
Articles by Omer Trivizki, MD, MBA
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Ophthalmology Times - Clinical Insights for Eye Specialists
1
Treatment-Resistant AMD Achieving Anatomical and Functional Gains With Aflibercept 8 mg
2
Vizz officially launches in the United States
3
David Lally discusses the ARCHER trial and the optimistic outcomes fueling future research
4
Lupin signs definitive agreement to acquire VISUfarma
5
.png "Optometry Times"){kind=logo}
